March 2022: In the neoadjuvant setting, the FDA approved nivolumab (Opdivo, Bristol-Myers Squibb Company) in combination with platinum-doublet chemotherapy for adult patients with resectable non-small cell lung cancer (NSCLC).Thi..
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,
Welcome to CancerFax !
CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.
Let us know what we can do for you.
1) Cancer treatment abroad? 2) CAR T-Cell therapy 3) Cancer vaccine 4) Online video consultation 5) Proton therapy